SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-065807
Filing Date
2017-03-01
Accepted
2017-03-01 16:28:57
Documents
3
Period of Report
2017-03-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d356271d8k.htm 8-K 15292
2 EX-99.1 d356271dex991.htm EX-99.1 73208
3 GRAPHIC g356271030117pbyi4q16pr-fina.jpg GRAPHIC 5954
  Complete submission text file 0001193125-17-065807.txt   98028
Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Filer) CIK: 0001401667 (see all company filings)

IRS No.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35703 | Film No.: 17654556
SIC: 2834 Pharmaceutical Preparations